top of page
NeuroSigma Announces Promotion of Dr. Colin Kealey to President
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) - NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion...
NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KT Significant investment...
Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
SAN DIEGO, CA, November 3, 2021 (GLOBE NEWSWIRE) – Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today...
Press
bottom of page